CIK 0000921299
- Non-accelerated filer
- Smaller reporting company
KYNTRA BIO, INC.
Sign in to watch- Ticker
- KYNB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 770357827
- Phone
- +1 415-978-1200
- Business address
- 350 BAY STREET, SUITE 100 #6009, SAN FRANCISCO, CA, 94133
- Former names
- FIBROGEN INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-03-16 | Yu K Peony Chief Medical Officer | Exercise or conversion · Stock Option (Right to Buy) | −3,750 | 56,250 | ||
| 2020-03-16 | Cotroneo Pat SVP, Finance and CFO | Sale | −9,239 | $26.36 | $244K | 236,466 |
| 2020-03-06 | Chung Christine SVP, China Operations | Shares withheld for taxes | −10,126 | $39.71 | $402K | 122,518 |
| 2020-03-06 | Yu K Peony Chief Medical Officer | Shares withheld for taxes | −9,826 | $39.71 | $390K | 162,791 |
| 2020-03-06 | Kouchakji Elias SVP, Clinical Dev, Drug Safety | Shares withheld for taxes | −6,525 | $39.71 | $259K | 94,691 |
| 2020-03-06 | Cotroneo Pat SVP, Finance and CFO | Shares withheld for taxes | −4,881 | $39.71 | $194K | 245,705 |
| 2020-02-12 | Chung Christine SVP, China Operations | Exercise or conversion | +5,625 | $25.40 | $143K | 138,269 |
| 2020-02-12 | Chung Christine SVP, China Operations | Sale | −5,025 | $45.94 | $231K | 133,244 |
| 2020-02-12 | Chung Christine SVP, China Operations | Sale | −600 | $46.28 | $28K | 132,644 |
| 2020-02-12 | Chung Christine SVP, China Operations | Exercise or conversion · Stock Option (Right to Buy) | −5,625 | 42,464 | ||
| 2020-02-11 | Chung Christine SVP, China Operations | Exercise or conversion | +5,625 | $25.40 | $143K | 138,269 |
| 2020-02-11 | Chung Christine SVP, China Operations | Sale | −5,625 | $44.48 | $250K | 132,644 |
| 2020-02-11 | Chung Christine SVP, China Operations | Exercise or conversion · Stock Option (Right to Buy) | −5,625 | 48,089 | ||
| 2020-02-10 | Kurkijarvi Kalevi Director | Exercise or conversion | +6,000 | $18.34 | $110K | 34,400 |
| 2020-02-10 | Kurkijarvi Kalevi Director | Sale | −6,000 | $42.69 | $256K | 28,400 |
| 2020-02-10 | Kurkijarvi Kalevi Director | Exercise or conversion · Stock Option (Right to Buy) | −6,000 | 6,000 | ||
| 2020-01-07 | Chung Christine SVP, China Operations | Exercise or conversion | +5,625 | $25.40 | $143K | 138,269 |
| 2020-01-07 | Chung Christine SVP, China Operations | Sale | −5,625 | $42.76 | $241K | 132,644 |
| 2020-01-07 | Chung Christine SVP, China Operations | Exercise or conversion · Stock Option (Right to Buy) | −5,625 | 53,714 | ||
| 2020-01-06 | Schoeneck James A Interim President | Shares withheld for taxes | −10,928 | $43.35 | $474K | 22,422 |
Page 23 of 33 · 651 trades